Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the ...

Thirty years after scientists demonstrated how brain implants can help rhesus monkeys move robotic limbs using only their ...

The brain implant company is adding office and manufacturing space in Del Valle facilities and hiring for jobs on software, engineer and brain interface teams.

Brain-computer interfaces are a groundbreaking technology that can help paralyzed people regain functions they’ve lost, like moving a hand. These devices record signals from the brain and decipher the ...

Momentum behind brain-computer interfaces is growing, but experts say that design innovations are needed to help them survive ...

Improving social communication skills in children with autism has traditionally relied on structured teaching approaches and ...

One of the boldest emerging sciences is the field of brain-computer interfaces (BCIs). Broadly speaking, BCIs are essentially tools by which brain signals and thoughts can be relayed into tangible ...

Looser regulation and new investment are helping groups such as NeuroXess accelerate trials of ‘brain-computer interfaces’ ...

Brain-Computer Interfaces (BCIs) are emerging as transformative tools that enable direct communication between the human brain and external devices. With recent advancements in Electroencephalography ...

A few weeks ago, I attended SXSW in Austin, Texas. The conference's purpose was to bring together creatives and technologists to build the future. I spent most of my time attending talks related to AI ...

Researchers at UC San Francisco have achieved a remarkable breakthrough in brain-computer interface (BCI) technology, enabling individuals with paralysis to control robotic devices through thought ...

China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.